Genetic Variants Found to Reduce Effectiveness of GLP-1 Drugs in 10 Percent of Type 2 Diabetes Patients – geneonline.com(Soban News)

1. Genetic Variants Found to Reduce Effectiveness of GLP-1 Drugs in 10 Percent of Type 2 Diabetes Patients  geneonline.com
2. Struggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle  NDTV
3. Genetic predictors of GLP1 receptor agonist weight loss and side effects  Nature
4. New Nature study could someday lead to DNA test that predicts which anti-obesity drug works for you  ThePrint
5. Genetic variants in 1 in 10 people may reduce blood‑sugar response to GLP‑1 diabetes drugs  Medical Xpress

​Genetic Variants Found to Reduce Effectiveness of GLP-1 Drugs in 10 Percent of Type 2 Diabetes Patients  geneonline.comStruggling To Lose Weight On Ozempic, Mounjaro? Study Says Your Genes Might Be the Hurdle  NDTVGenetic predictors of GLP1 receptor agonist weight loss and side effects  NatureNew Nature study could someday lead to DNA test that predicts which anti-obesity drug works for you  ThePrintGenetic variants in 1 in 10 people may reduce blood‑sugar response to GLP‑1 diabetes drugs  Medical Xpress by Soban News (international And National News)